Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 1387430

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 1387430

Bavine Ephermal Fever Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4850
PDF (2 Users License)
USD 5800
PDF (5 Users License)
USD 6700
PDF (Corporate License)
USD 8850

Add to Cart

Bavine Ephermal Fever Vaccine Trends and Forecast

The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets. The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

A more than 150-page report is developed to help in your business decisions.

Bavine Ephermal Fever Vaccine by Segment

The study includes a forecast for the global bavine ephermal fever vaccine by type, application, end use, and region.

Bavine Ephermal Fever Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Live Vaccines
  • Killed Vaccines
  • Others

Bavine Ephermal Fever Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cattle
  • Water Buffaloes
  • Others

Bavine Ephermal Fever Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Medical Device Companies
  • Pharmaceutical Industries
  • Animal Hospitals
  • Others

Bavine Ephermal Fever Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bavine Ephermal Fever Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bavine ephermal fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bavine ephermal fever vaccine companies profiled in this report include-

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals

Bavine Ephermal Fever Vaccine Market Insights

Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Features of the Global Bavine Ephermal Fever Vaccine Market

Market Size Estimates: Bavine ephermal fever vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bavine ephermal fever vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bavine ephermal fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the bavine ephermal fever vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bavine ephermal fever vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bavine ephermal fever vaccine market?

Answer: The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bavine ephermal fever vaccine market?

Answer: The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

Q3. What are the major segments for bavine ephermal fever vaccine market?

Answer: The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets.

Q4. Who are the key bavine ephermal fever vaccine market companies?

Answer: Some of the key bavine ephermal fever vaccine companies are as follows:

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals

Q5. Which bavine ephermal fever vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

Q6. In bavine ephermal fever vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bavine ephermal fever vaccine market by type (live vaccines, killed vaccines, and others), application (cattle, water buffaloes, and others), end use (medical device companies, pharmaceutical industries, animal hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bavine Ephermal Fever Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bavine Ephermal Fever Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bavine Ephermal Fever Vaccine Market by Type
    • 3.3.1: Live Vaccines
    • 3.3.2: Killed Vaccines
    • 3.3.3: Others
  • 3.4: Global Bavine Ephermal Fever Vaccine Market by Application
    • 3.4.1: Cattle
    • 3.4.2: Water Buffaloes
    • 3.4.3: Others
  • 3.5: Global Bavine Ephermal Fever Vaccine Market by End Use
    • 3.5.1: Medical Device Companies
    • 3.5.2: Pharmaceutical Industries
    • 3.5.3: Animal Hospitals
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bavine Ephermal Fever Vaccine Market by Region
  • 4.2: North American Bavine Ephermal Fever Vaccine Market
    • 4.2.2: North American Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.3: European Bavine Ephermal Fever Vaccine Market
    • 4.3.1: European Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.3.2: European Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.4: APAC Bavine Ephermal Fever Vaccine Market
    • 4.4.1: APAC Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.4.2: APAC Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.5: ROW Bavine Ephermal Fever Vaccine Market
    • 4.5.1: ROW Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.5.2: ROW Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Bavine Ephermal Fever Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bavine Ephermal Fever Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bavine Ephermal Fever Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zoetis Services
  • 7.2: Nutri Pharmax
  • 7.3: Octavoscene
  • 7.4: Kyoto Biken Laboratories
  • 7.5: Indian Immunologicals
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!